Filing Details
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:PRAX
Praxis Precision Medicines, Inc. (PRAX) Reports Material Event to SEC
Filing Details Praxis Precision Medicines, Inc. (NASDAQ:PRAX) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market…
Market Context
Praxis Precision Medicines, Inc.'s stock currently trades at $318.52 with a market capitalization of $5.7B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Praxis Precision Medicines, Inc.'s stock.
All SEC filings for Praxis Precision Medicines, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PRAX Stock Page
Frequently Asked Questions
Where can I read PRAX's SEC filings?
Browse all filings on our PRAX SEC filings page.
What types of SEC filings does Praxis Precision Medicines, Inc. file?
Public companies like Praxis Precision Medicines, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.